The combination treatment of RC48 and STAT3 inhibitor acts as a promising therapeutic strategy for basal bladder cancer - Li, Jingxian; Shan, Kun; Huang, Wei; Su, Qiang; Qi, Yuanjiong; Zhang, Zhihong; Zhu, Jianqiang; Du, E. (Frontiers in Immunology, 2025)